Xeris Biopharma (XERS) Proxy filing summary

Voting matters and shareholder proposals

• Election of two Class II directors, Dawn Halkuff and John Johnson, to serve until the 2029 Annual Meeting or until successors are elected.

• Ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.

• Advisory vote to approve the compensation of named executive officers.

• Other business may be addressed at the meeting at the discretion of the named proxies.

Board of directors and corporate governance

• Board recommends voting for all director nominees and for both proposals on the agenda.

Executive compensation and say-on-pay

• Shareholders will vote on a non-binding advisory basis to approve executive compensation.